SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-16-633287
Filing Date
2016-06-27
Accepted
2016-06-27 17:20:32
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D d220314dsc13d.htm SC 13D 60714
  Complete submission text file 0001193125-16-633287.txt   62423
Mailing Address 3181 PORTER DRIVE PALO ALTO CA 94304
Business Address 3181 PORTER DRIVE PALO ALTO CA 94304 650-855-6777
Carbylan Therapeutics, Inc. (Subject) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88797 | Film No.: 161734123
SIC: 2834 Pharmaceutical Preparations

Mailing Address BUILDING 227, TETRICUS SCIENCE PARK PORTON DOWN, SALISBURY WILTSHIRE X0 SP4 0JQ
Business Address BUILDING 227, TETRICUS SCIENCE PARK PORTON DOWN, SALISBURY WILTSHIRE X0 SP4 0JQ 4401980753002
KalVista Pharmaceuticals Ltd (Filed by) CIK: 0001678087 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0430
Type: SC 13D